Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q59274329)
Watch
English
How could pharmacogenomics help improve patient survival?
scientific article published on 01 August 2007
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
title
How could pharmacogenomics help improve patient survival?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
main subject
pharmacogenomics
1 reference
based on heuristic
inferred from title
author
Enriqueta Felip
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string
Luis Paz-Ares
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
Rafael Rosell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
publication date
1 August 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
published in
Lung Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
volume
57 Suppl 2
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
page(s)
S35-41
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
cites work
Erlotinib in previously treated non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Update on epidermal growth factor receptor mutations in non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Understanding the new genetics of responsiveness to epidermal growth factor receptor tyrosine kinase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA repair and cisplatin resistance in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0169-5002%2807%2970426-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0169-5002(07)70426-9
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
PubMed ID
17686445
1 reference
stated in
Europe PubMed Central
PubMed ID
17686445
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17686445%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit